Disease / condition
Crohn's Disease clinical trials
Free access to 508 studies10+ countriesUpdated daily43 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
508
Total trials
10+
Countries
10+
Sponsors
43
Recruiting
By phase
N/A183
Phase 3110
Phase 2106
Phase 443
Early Phase 129
By status
Completed270
Terminated74
Unknown54
Recruiting43
Not yet recruit...27
Top countries
United States of America91
Israel22
France20
China20
Japan18
Top sponsors
AbbVie25
Abbott14
Takeda13
UCB Pharma12
GlaxoSmithKline10
Recent trials
Latest clinical trials for Crohn's Disease
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Janssen-Cilag Ltd. · Israel,Taiwan
NCT06408935Recruiting
- Phase
- Phase 3
Evaluation of Enteral Nutrition Biscuits for Inducing Remission in Moderate-to-severe Crohn's Disease
Ping An
NCT06362863Not yet recr...
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
AbbVie
NCT06332534Not yet recr...
- Phase
- Phase 3
Capsule & Omics for pRedicting Exacerbation of Crohn's Disease
Sheba Medical Center · Israel
NCT06362174Recruitment ...
VOICE-Early Response to Vedolizumab and Ustekinumab in Participants With Crohn's Disease: A Prospective Observational Study
Alimentiv Inc.
NCT06249555Not yet recr...
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Takeda
NCT06233461Not yet recr...
- Phase
- Phase 2
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Takeda
NCT06227910Not yet recr...
- Phase
- Phase 3
TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study
Hospices Civils de Lyon · France
NCT06244849Not yet recr...
Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease
University Hospital, Montpelli... · France
NCT06299631Completed
An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK)
AbbVie · United Kingdom
NCT06126146Recruiting
MRE Predictors of Disease Relapse After Stopping Biologics
University College, London
NCT06124287Not yet recr...
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
AbbVie · United States of America
NCT06063967Recruiting
- Phase
- Phase 3
Untitled Trial
Janssen Pharmaceutical K.K. · Australia;Belgium;Brazil;Canada;Switzerland;Czech;Spain;France;United Kingdom of Great Britain;Israe
jRCT2031230352Not yet recr...
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Takeda · United States of America
NCT06045754Not yet recr...
- Phase
- Phase 4
Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
Asan Medical Center · South Korea
NCT06064864Not yet recr...
Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease
AstraZeneca · Sweden
NCT06053424Recruiting
- Phase
- Phase 1
An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan
AbbVie · Japan
NCT06023030Recruiting
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
AbbVie · United States of America
NCT05995353Recruiting
- Phase
- Phase 3
Analysis of intestinal mucosa and fat nearby the intestine in patients with Crohn's disease
Hospital de Clínicas - Univers... · Brazil
RBR-79h2ppxRecruiting
Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.
AbbVie
NCT05930275Not yet recr...
About this profile
Access comprehensive clinical trial information for Crohn's Disease through Pure Global AI's free database. This collection includes 508 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 43 trials are actively recruiting participants.
Research for Crohn's Disease is being conducted in United States of America, Israel, France and 7+ other countries. Leading sponsors include AbbVie and Abbott. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 508 clinical trials studying Crohn's Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AbbVie, Abbott, Takeda, among others.